ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.

Jonathan Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.